Butterflly is a digital therapeutics company focused on safe, evidenced-based, highly personalized, and de-stigmatized behavioral health. Users leverage person-generated data and the therapeutic power of peer groups inside secure social media-style private networks. Extended services also include coaching and telehealth therapy.

Cognoa is developing digital products intended to support healthcare providers in expediting diagnosis with the goal of improving access to timely intervention for children and families, starting with autism spectrum disorder (ASD).

We are developing digital diagnostic and therapeutic products with the goal of enabling earlier and more equitable care for behavioral health conditions.

We deliver culturally-centered, intersectional and evidence-based care for teens and adults from all walks of life while also providing an alternative to in-person therapy that is more affordable and accessible.

Cognoa seeks to help improve the lives and outcomes of children and their families living with behavioral health conditions. We strive to improve timely, equitable access to a diagnosis for caregivers with early concerns of developmental delay, including autism, to support opportunities for early intervention and improved outcomes for children and their families.